International Child Development Resource Center

The International Child Development Resource Center (ICDRC) was a specialized healthcare and research organization focused on alternative treatments for autism spectrum disorders (ASD). Founded by Dr. Jeff Bradstreet, the center was known for promoting and researching controversial therapies, including chelation therapy for heavy metal detoxification and the use of GcMAF (Globulin component Macrophage Activating Factor). While it operated as a clinical facility providing direct patient care, it also engaged in non-traditional research into the environmental and biological causes of neurodevelopmental conditions. The center ceased its primary operations following the death of its founder in 2015 and significant regulatory scrutiny regarding the use of unapproved biological products. It remains a notable entity in the history of alternative biomedical interventions for autism.